Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of 3D Systems Corporation securities between August 13, 2024, and May 12, 2025, due to alleged misleading statements made by the company [1][5]. Group 1: Lawsuit Details - The class action lawsuit claims that 3D Systems made false and misleading statements regarding the impact of weakened customer spending and overstated its resilience in challenging industry conditions [5]. - The lawsuit also alleges that updated milestone criteria in a partnership with United Therapeutics Corporation would negatively affect 3D Systems' Regenerative Medicine Program revenue [5]. - Investors are encouraged to join the class action, with no out-of-pocket fees or costs through a contingency fee arrangement [2][3]. Group 2: Participation Information - Interested parties can join the class action by visiting the provided link or contacting the law firm directly [3][6]. - A lead plaintiff must move the Court by August 12, 2025, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including over $438 million for investors in 2019 [4]. - The firm has been recognized for its success in securities class action settlements and has consistently ranked among the top firms in this area since 2013 [4].

Core Viewpoint - A class action has been filed against 3D Systems Corporation for allegedly misleading investors regarding its business prospects and financial performance [1][2]. Group 1: Allegations and Financial Performance - The complaint alleges that 3D Systems understated the impact of weakened customer spending and overstated its resilience in challenging industry conditions [2]. - The updated milestone criteria in the United Partnership are claimed to negatively impact the revenue of the Company's Regenerative Medicine Program [2]. - On March 26, 2025, 3D Systems announced disappointing financial results for Q4 and full-year 2024, leading to a stock price drop of $0.57 per share, or 20.96%, closing at $2.15 on March 27, 2025 [3]. - For Q1 2025, 3D Systems reported revenue of $94.5 million, down 8% year-over-year, missing consensus estimates of $99.5 million, and a net loss of $37 million, or $0.28 per share, more than doubling the $16 million loss from Q1 2024 [4]. - The adjusted loss per share was $0.21, deeper than the consensus estimate of a loss of $0.14, and adjusted EBITDA showed a loss of $23.9 million, worsening from a $20.1 million loss in Q1 2024 [4]. - The Company attributed its disappointing results to a decline in material sales, particularly due to inventory management issues in the dental segment of its Healthcare Solutions [4]. - 3D Systems withdrew its full-year 2025 outlook, citing prolonged softness in customer capital spending and macroeconomic uncertainty [4]. - Following the Q1 results announcement, the stock price fell $0.68 per share, or 26.6%, closing at $1.87 on May 13, 2025 [4].

ATLANTA, June 16, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against 3D Systems Corporation (“3D Systems” or the “Company”) (NYSE: DDD). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse information regarding 3D Systems’ business, operations, and compliance policies, including allegations that: (i) 3D Systems had understated the impact of weakened customer spending on the Company’s business, while ...

Core Viewpoint - A class action has been filed against 3D Systems Corporation for allegedly misleading investors about its business prospects, particularly regarding customer spending and revenue impacts from updated milestone criteria in its Regenerative Medicine Program [1][2]. Financial Performance - On March 26, 2025, 3D Systems announced disappointing financial results for Q4 and full-year 2024, leading to a stock price drop of $0.57 per share, or 20.96%, closing at $2.15 on March 27, 2025 [3]. - For Q1 2025, 3D Systems reported revenue of $94.5 million, down 8% year-over-year, missing consensus estimates of $99.5 million. The company also reported a net loss of $37 million, or $0.28 per share, more than doubling the $16 million loss from Q1 2024 [4]. - The adjusted loss per share was $0.21, worse than the consensus estimate of a loss of $0.14 per share, and adjusted EBITDA showed a loss of $23.9 million, worsening from a $20.1 million loss in Q1 2024 [4]. - The company withdrew its full-year 2025 outlook due to prolonged softness in customer capital spending and macroeconomic uncertainty, resulting in a further stock price decline of $0.68 per share, or 26.6%, closing at $1.87 on May 13, 2025 [4].

Core Viewpoint - 3D Systems has experienced a decline of approximately 1.6% in share price over the past month, underperforming the S&P 500, raising questions about its future performance leading up to the next earnings release [1] Estimates Movement - Estimates for 3D Systems have remained flat over the past month, with the consensus estimate shifting down by 6.67% [2] VGM Scores - The company holds a Growth Score of B, but significantly lags in Momentum Score with an F, and also has a Value Score of F, placing it in the fifth quintile for this investment strategy; the overall aggregate VGM Score is D [3] Outlook - 3D Systems is assigned a Zacks Rank of 4 (Sell), indicating expectations of below-average returns in the upcoming months [4]

Core Insights - 3D Systems is collaborating with Penn State University and Arizona State University on NASA-sponsored projects to develop advanced thermal management solutions for spacecraft [1][5][6] - The projects focus on creating lightweight, efficient heat pipe radiators using additive manufacturing technologies, specifically targeting next-generation satellites and space exploration [1][2][6] Group 1: Project Details - The collaboration has led to the development of titanium heat pipe radiators that are 50% lighter and can operate at temperatures of 230°C, enhancing heat transfer efficiency for space applications [2][5] - A significant innovation includes the creation of a passive shape memory alloy (SMA) radiator using nitinol, which has a projected deployed-to-stowed area ratio 6 times larger than current solutions, allowing for more efficient use of space in CubeSats [1][3][5] Group 2: Technological Advancements - The use of Oqton's 3DXpert® software has enabled the embedding of a porous network within heat pipes, streamlining the manufacturing process and improving performance [2][3] - The passive SMA radiator can be deployed without motors, relying on heat from fluid inside, which simplifies the design and reduces potential points of failure in space [3][4] Group 3: Market Potential - The total addressable market for additive manufacturing in space applications is projected to reach nearly $4 billion by 2030, indicating significant growth opportunities for 3D Systems [5][6] - The global market for additive manufacturing in the aerospace industry was estimated at $1.2 billion in 2023 and is expected to grow to $3.8 billion by 2030, highlighting the increasing adoption of these technologies [6]

Analyst's Disclosure: I/we have a beneficial long position in the shares of MTLS either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any i ...

Core Viewpoint - 3D Systems reported a wider-than-expected non-GAAP loss in Q1 2025, indicating ongoing challenges in revenue generation and market conditions [1][2][11] Financial Performance - The company incurred a non-GAAP loss of 21 cents per share, compared to a loss of 17 cents per share in the same quarter last year [1] - Revenues for the quarter were $94.5 million, down 8.1% year over year, and missed the Zacks Consensus Estimate by 3.91% [2] - Product revenues decreased by 14.6% year over year to $54.7 million, while services revenues increased by 2.5% to $39.8 million [3][4] - Non-GAAP gross profit fell 19.7% year over year to $33.1 million, with a gross profit margin decline of 500 basis points to 35% [6] Segment Performance - Healthcare Solutions revenues decreased by 9% year over year to $41.3 million, while Industrial Solutions revenues declined by 7.5% to $53.2 million [5][6] - The Personalized Healthcare business grew by 17%, and manufacturing operations for FDA-approved parts increased by 18%, indicating strong demand in critical markets [6] Operational Metrics - Adjusted EBITDA showed a loss of $23.9 million, down $3.8 million year over year, primarily due to lower volumes and unfavorable pricing [7] - As of March 31, 2025, cash and cash equivalents were $135 million, down from $171.3 million at the end of 2024, with total debt slightly increasing to $212.3 million [8] Strategic Developments - The sale of the Geomagic portfolio in April improved liquidity, adding over $100 million to cash reserves, totaling approximately $250 million as of April 30, 2025 [9] - The company has withdrawn its full-year 2025 guidance due to uncertainties in capital expenditures but remains focused on achieving profitability [10][11] Market Outlook - The Zacks Consensus Estimate for 2025 revenues is $427.61 million, suggesting a year-over-year decline of 2.84%, with an expected loss of 39 cents per share [12]

3D Systems (DDD) Q1 2025 Earnings Call May 13, 2025 08:30 AM ET Company Participants Mick McCloskey - Treasurer & Vice President of Investor RelationsDr. Jeffrey Graves - President and CEOJeffrey Creech - Executive VP & CFOTroy Jensen - Managing DirectorBrian Drab - Co-Group Head–IndustrialsAlek Valero - Equity Research Associate Conference Call Participants Greg Palm - Senior Research Analyst Operator Greetings. Welcome to three d Systems First Quarter twenty twenty five Earnings Call. At this time, all pa ...

Financial Data and Key Metrics Changes - For Q1 2025, consolidated revenues were $95 million, an 8% decline from the previous year, primarily due to a decrease in materials sales [30][31] - Non-GAAP gross profit margin was 35%, down from 40% in the prior year, driven by lower volumes and unfavorable price and mix [32] - EBITDA for the quarter was negative $23.9 million, a decline of $4 million from the previous year [34] Business Line Data and Key Metrics Changes - Industrial Solutions revenues were $53 million, a 7% decline, primarily due to lower materials sales, although printer sales and success in aerospace and defense markets provided some offset [31] - Healthcare Solutions revenues decreased by 9% to $41 million, with growth in services offset by declines in materials and flat printer sales [32] - Personalized healthcare and parts manufacturing revenues grew by 1817% and 1718% respectively, indicating strong performance in these segments [24] Market Data and Key Metrics Changes - The dental market is projected to have a total addressable market of $1 billion in the U.S., with Europe and Asia potentially doubling this figure [16][20] - The aligner market continues to grow, although there is volatility due to inventory management and just-in-time sourcing strategies by key manufacturers [40][42] Company Strategy and Development Direction - The company is focusing on cost reduction initiatives, aiming for $70 million in total cost savings over the next two years, with an immediate goal of achieving positive EBITDA [14][15][28] - The strategy includes a shift towards high-reliability markets such as aerospace, defense, and oil and gas, while maintaining a strong position in personalized healthcare [52][92] - The company is committed to maintaining R&D investment at over 20% of revenue, despite current economic challenges, to ensure long-term growth and innovation [11][80] Management's Comments on Operating Environment and Future Outlook - Management expressed concerns about weak sales due to frozen capital spending across most markets, with the exception of personalized healthcare, defense, and AI infrastructure [8][10] - The outlook for 2025 is conservative due to ongoing economic and geopolitical instabilities, leading to the withdrawal of full-year guidance [27][37] - The company remains optimistic about future growth once customer capital spending rebounds, supported by a strong product portfolio [37] Other Important Information - The company completed the sale of its GeoMagic asset portfolio, generating over $100 million in net proceeds, which strengthens its cash position [29][35] - The company is currently in a net cash positive position, with approximately $250 million in cash following the GeoMagic sale [36] Q&A Session Summary Question: Can you comment on aligner inventory and the movement to just-in-time? - Management noted that the aligner market continues to grow, but companies are becoming more sophisticated in inventory management, leading to increased volatility in forecasts [40][42] Question: What are the options regarding debt maturity in 18 months? - Management is exploring various options, including paying off debt or rolling it forward, and is currently assessing the balance sheet following the GeoMagic sale [78] Question: How will cost cuts affect growth? - Management emphasized the importance of maintaining R&D spending while focusing on profitable markets, particularly in healthcare and high-reliability industrial sectors [80][86]